324 related articles for article (PubMed ID: 28558091)
41. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
42. Internet-Based Information on Long-Acting Reversible Contraception for Adolescents.
Harris K; Byrd K; Engel M; Weeks K; Ahlers-Schmidt CR
J Prim Care Community Health; 2016 Apr; 7(2):76-80. PubMed ID: 26643120
[TBL] [Abstract][Full Text] [Related]
43. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
Kavanaugh ML; Jerman J; Ethier K; Moskosky S
J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980
[TBL] [Abstract][Full Text] [Related]
44. Awareness of long-acting reversible contraception among teens and young adults.
Teal SB; Romer SE
J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
[TBL] [Abstract][Full Text] [Related]
45. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
46. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
Farah D; Andrade TRM; Di Bella ZIKJ; GirĂ£o MJBC; Fonseca MCM
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
[TBL] [Abstract][Full Text] [Related]
47. Preventing unintended pregnancies by providing no-cost contraception.
Peipert JF; Madden T; Allsworth JE; Secura GM
Obstet Gynecol; 2012 Dec; 120(6):1291-7. PubMed ID: 23168752
[TBL] [Abstract][Full Text] [Related]
48. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
Secura G
Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
[TBL] [Abstract][Full Text] [Related]
49. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
[TBL] [Abstract][Full Text] [Related]
50. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
51. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
Sapkota S; Rajbhandary R; Lohani S
Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
[TBL] [Abstract][Full Text] [Related]
52. Long-Acting Reversible Contraception for Adolescents.
Fontenot HB; Fantasia HC
Nurs Womens Health; 2015; 19(3):253-9. PubMed ID: 26058908
[TBL] [Abstract][Full Text] [Related]
53. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
54. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
[TBL] [Abstract][Full Text] [Related]
55. "The thing in my arm": Providing contraceptive services for adolescents in primary care.
Lewin A; Skracic I; Brown E; Roy K
Womens Health (Lond); 2024; 20():17455057241248399. PubMed ID: 38778774
[TBL] [Abstract][Full Text] [Related]
56. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
57. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
[TBL] [Abstract][Full Text] [Related]
58. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
[TBL] [Abstract][Full Text] [Related]
59. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
Dodson NA; Gray SH; Burke PJ
Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
[TBL] [Abstract][Full Text] [Related]
60. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
Pritt NM; Norris AH; Berlan ED
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]